Physician
Urology
Dr. Michael M. Lieber, MD
|
|
Give Review
Michael Lieber practices Urology. He studied medicine at Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School is ranked 1 in research and 12 in primary care medicine Dr. Michael M. Lieber is also published. He has 64 publications published. The lastest publication: "Factors Associated with Adherence to an End-of-Study Biopsy: Lessons from the Prostate Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S9217).'
Publications
- Factors Associated with Adherence to an End-of-Study Biopsy: Lessons from the Prostate Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S9217).
- Racial Differences in Longitudinal Changes in Serum Prostate-specific Antigen Levels: The Olmsted County Study and the Flint Men's Health Study.
- Effectiveness of medical and surgical therapies for lower urinary tract symptoms in the community setting.
- Nocturia is associated with an increased risk of coronary heart disease and death.
- Distribution and associations of [-2]proenzyme-Prostate specific antigen in community dwelling black and white men.
- Benign Prostate specific antigen distribution and associations with urological outcomes in community dwelling black and white men.
- Vitamin E and the risk of Prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
- Fracture risk in men with Prostate cancer: A population-based study.
- Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign Prostate enlargement.
- Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes.
- Estimation of Prostate size in community-dwelling men.
- The association between statin use and the diagnosis of Prostate cancer in a population based cohort.
- Intravesical prostatic protrusion in men in Olmsted County, Minnesota.
- Three-dimensional ultrasound bladder characteristics and their association with Prostate size and lower urinary tract dysfunction among men in the community.
- Longitudinal evaluation of sexual function in a male cohort: the Olmsted county study of urinary symptoms and health status among men.
- Alpha-blocker use is associated with decreased risk of sexual dysfunction.
- Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort.
- Smoking and acute urinary retention: the Olmsted County study of urinary symptoms and health status among men.
- A population-based, longitudinal study of erectile dysfunction and future coronary artery disease.
- Effect of selenium and vitamin E on risk of Prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
- Psychosocial factors associated with an increased frequency of Prostate cancer screening in men ages 40 to 79 years: the Olmsted County study.
- The associations between serum sex hormones, erectile function, and sex drive: the Olmsted County Study of Urinary Symptoms and Health Status among Men.
- Snoring as a risk factor for sexual dysfunction in community men.
- Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men.
- Longitudinal association between prostatitis and development of benign prostatic hyperplasia.
- Population-based case-control study of PSA and DRE screening on Prostate cancer mortality.
- Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men.
- Radical Prostatectomy for octogenarians: how old is too old?
- Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia.
- Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia.
- Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia.
- Tracking of longitudinal changes in measures of benign prostatic hyperplasia in a population based cohort.
- PDLIM4 repression by hypermethylation as a potential biomarker for Prostate cancer.
- Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men.
- Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota.
- Longitudinal changes in post-void residual and voided volume among community dwelling men.
- Cross-sectional associations of urogenital pain and sexual function in a community based cohort of older men: olmsted county, Minnesota.
- The association between benign prostatic hyperplasia and chronic kidney disease in community-dwelling men.
- A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
- Limitations of using outcomes in the placebo arm of a clinical trial of benign prostatic hyperplasia to quantify those in the community.
- Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH.
- Is benign prostatic hyperplasia a risk factor for chronic renal failure?
- Association between smoking and erectile dysfunction: a population-based study.
- Monitoring intravesical therapy for superficial bladder Cancer using fluorescence in situ hybridization.
- Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
- Extended and saturation needle biopsy for the diagnosis of Prostate cancer.
- Lower urinary tract symptoms and sexual dysfunction in community-dwelling men.
- Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia.
- Inverse association between Prostate cancer and the use of calcium channel blockers.
- Low agreement between previous physician diagnosed prostatitis and national institutes of health chronic prostatitis symptom index pain measures.
- Prostatitis as a risk factor for Prostate cancer.
- Probasin promoter (ARR(2)PB)-driven, Prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of Prostate cancer.
- The influence of finasteride on the development of Prostate cancer.
- Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia.
- Update on oncocytoma.
- Frequency of sexual activity and prostatic health: fact or fairy tale?
- Prevalence of prostatitis-like symptoms in a community based cohort of older men.
- Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined Prostate cancer.
- A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.
- Mapping and gene expression profile of the minimally overrepresented 8q24 region in Prostate cancer.
- A population-based study of daily nonsteroidal anti-inflammatory drug use and Prostate cancer.
- Trends and risk factors for Prostate biopsy complications in the pre-PSA and PSA eras, 1980 to 1997.
- Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) Prostate cancer are potential markers for cancer progression.
Schools
Harvard Medical School
Massachusetts General Hospital
University Calif Hospital
National Canc Institute
Conditions Treated
- Prostate Cancer
Doctors Specialties
- Urology
Accepted Insurances
Education
-
VA Greater Los Angeles Healthcare System -
Massachusetts General Hospital -
Harvard Medical School
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1619990116 |
| Last Name Of The Provider | LIEBER |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Lance A. Mynderse, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew T. Gettman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Alonso Carrasco Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew T. Blackburne, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew N. McCall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James R. Craig Jr., MD |
|
|
Dr. Brian J. Linder, MD |
|
|
Dr. Marcelino E. Rivera, MD
This Doctor is OpenDoctor Recommended.
|